Quest Partners LLC Pliant Therapeutics, Inc. Transaction History
Quest Partners LLC
- $575 Billion
- Q1 2024
A detailed history of Quest Partners LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 18,298 shares of PLRX stock, worth $235,495. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,298
Previous 2,051
792.15%
Holding current value
$235,495
Previous $37.1 Million
634.01%
% of portfolio
0.05%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PLRX
# of Institutions
149Shares Held
63.9MCall Options Held
417KPut Options Held
123K-
Deep Track Capital, LP Greenwich, CT5.75MShares$74 Million2.83% of portfolio
-
Black Rock Inc. New York, NY4.66MShares$59.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.96MShares$51 Million0.01% of portfolio
-
First Light Asset Management, LLC Edina, MN3.53MShares$45.5 Million4.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.48MShares$44.8 Million0.0% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $627M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...